Zero-shot clinical trial patient matching with LLMs
Mechanistic Focus in Research Within experimental laboratory settings, Tesamorelin / Ipamorelin is commonly studied in relation to peptide-mediated signalling pathways
Interestingly, frameshift mutations disrupting the C-terminal DNA binding interface of PDS5B (c.3939dup and c.3954del) have been identified in gastrointestinal cancers 37 , underscoring the possible significance of the PDS5B DNA binding attribute in tumor suppression, and indicating that cancers harboring PDS5B mutations could be targeted with PARP inhibitors 38
It has a long history of use in wound healing and skincare with an excellent safety record being nontoxic and effective at very low concentrations
see the GHK-Cu protocol guide for the full evidence picture
Its important to remember that the right number of injections depends on your condition, how your body responds, and your overall health.